An observational study of functional abilities in infants, children, and adults with type 1 SMA
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective To report cross-sectional clinical findings in a large cohort of patients affected by type 1 spinal muscular atrophy.
Methods We included 122 patients, of age ranging between 3 months and 22 years, 1 month. More than 70% (85/122) were older than 2 years and 25% (31/122) older than 10 years. Patients were classified according to the severity of phenotype and to the number of SMN2 copies.
Results Patients with the more common and the most severe phenotype older than 2 years were, with few exceptions, on noninvasive ventilation and, with increasing age, more often had tracheostomy or >16-hour ventilation and a gastrostomy inserted. In contrast, 25 of the 28 patients with the mildest phenotype older than 2 years had no need for tracheostomy or other ventilatory or nutritional support. In patients older than 2 years, the Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders scores were generally lower compared to those found in younger patients and showed distinct levels of functional abilities according to the severity of the phenotype. Similar findings were also observed on the Hammersmith Infant Neurological Examination.
Conclusions Our findings confirm that, after the age of 2 years, patients with type 1 spinal muscular atrophy generally survive only if they have gastrostomy and tracheostomy or noninvasive ventilation >16 hours and have low scores on the functional scales. More variability, however, can be expected in those with the mildest phenotype, who achieve head control. These data provide important baseline information at the time treatments are becoming available.
Glossary
- CHOP INTEND=
- Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders;
- EAP=
- early access program;
- HINE=
- Hammersmith Infant Neurological Examination;
- PEG=
- percutaneous endoscopic gastrostomy;
- SMA=
- spinal muscular atrophy
Footnotes
↵* These authors contributed equally to this work as first authors.
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
Italian EAP Working Group coinvestigators are listed at links.lww.com/WNL/A633.
Editorial, page 337
- Received March 15, 2018.
- Accepted in final form May 29, 2018.
- © 2018 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Sharon Poisson and Dr. Tiffany Brown
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
Intragenic variants in the SMN1 gene determine the clinical phenotype in 5q spinal muscular atrophyRodrigo de Holanda Mendonça, Ciro Matsui, Jr, Graziela Jorge Polido et al.Neurology: Genetics, September 01, 2020 -
Article
Population-based analysis of survival in spinal muscular atrophyCamiel A. Wijngaarde, Marloes Stam, Louise A.M. Otto et al.Neurology, March 26, 2020 -
Articles
SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALSJ. H. Veldink, S. Kalmijn, A. H. Van der Hout et al.Neurology, August 10, 2005 -
Editorial
Precious SMA natural history dataA benchmark to measure future treatment successesBasil T. Darras, Darryl C. De Vivo et al.Neurology, July 25, 2018